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M
any studies have too small 
a sample size for their 
ﬁ  ndings to be conclusive, 
but large studies are expensive and 
time-consuming. Meta-analysis is an 
alternative to conducting large studies 
in tackling the problem of small sample 
size, by combining available small 
studies to increase the total sample 
size. Since the 1980s, meta-analysis 
has been widely used in summarizing 
results from clinical trials of medical 
interventions and has also recently 
gained increasing attention in studying 
gene-disease associations. However, 
selection bias may occur in meta-
analyses due to the inability to identify 
and include all conducted and relevant 
studies. Such selection bias can cause 
exaggerated or even false-positive gene-
disease associations [1]. 
Failure to include all relevant studies 
is largely caused by selective publication 
of studies with certain results 
(publication bias), and the inability to 
identify studies published in languages 
other than English (language bias). 
Selection bias has been well recognized 
in meta-analyses of clinical trials [2–4]. 
Less is known about selection bias in 
meta-analyses of studies of gene-disease 
associations; such studies generally 
address weak associations and thus are 
particularly vulnerable to biases. 
A Study of the Chinese Literature
In their study published in this issue 
of PLoS Medicine, Pan and colleagues 
compared genetic studies conducted 
in mainland China with those from 
other places [5]. The researchers 
identiﬁ  ed 12 gene-disease associations 
and compared a total of 161 Chinese 
studies and 309 non-Chinese studies. 
The Chinese studies were on average 
smaller in sample size than non-
Chinese studies and appeared in the 
literature a few years after the ﬁ  rst 
non-Chinese studies. Chinese studies 
in general reported a stronger gene-
disease association and more frequently 
a statistically signiﬁ  cant result. These 
two characteristics were more likely 
to occur in Chinese studies identiﬁ  ed 
through PubMed than in those 
accessible only locally. 
These ﬁ  ndings suggest a variation 
or heterogeneity in the strength of 
the gene-disease association (often 
expressed in an odds ratio) observed 
between Chinese and non-Chinese 
studies. These studies are primarily 
case-control studies. Many factors 
may contribute to the variation in 
the estimate of odds ratio across such 
studies, such as the genetic make-up 
of the population studied, the type 
of patients included, the selection of 
controls, the quality of the study design, 
and the quality of the laboratory work. 
These factors could lead to either over- 
or under-estimation of the true odds 
ratio. However, it is difﬁ  cult to conceive 
that any single factor, or combination 
of these factors, could consistently 
cause the exaggerated odds ratio in 
Chinese studies in all the topics (gene-
disease associations) examined by Pan 
and colleagues. Selective publication 
is therefore a very likely and worrying 
explanation for their ﬁ  ndings.
Implications for Clinical Practice 
and Research
Selective publication can cause 
publication bias, which in turn could 
lead to false gene-disease associations 
in meta-analyses. It would be a disaster 
if a genetic screening program (in 
which healthy people are tested for a 
gene and offered a treatment if they 
test positive) were based on such a false 
association. Even if such a false gene-
disease association were only subjected 
to further related investigations, this 
would be a waste of valuable resources 
for medical research. 
Selective publication of positive 
studies in China and a few other Asian 
countries has been observed in clinical 
trials of acupuncture [6,7]. However, 
selective publication by no means exists 
in only the Chinese literature. It is 
probably a common phenomenon in 
the entire ﬁ  eld of biomedical research. 
Given the fact that positive studies 
are more likely to be published than 
negative ones, and given the pressure 
on researchers worldwide to publish 
in indexed journals (especially in 
international journals with high impact 
factors), selective publication is likely 
to continue in the foreseeable future. 
As compared with English-speaking 
countries, selective publication is 
perhaps more likely to occur in non-
English-speaking countries where there 
are a small number of indexed journals 
to publish local studies. 
Addressing the Problem
Journals accessible through PubMed or 
other major biomedical databases are 
unlikely to have the same mechanism 
of selection for publication as local 
journals that are less accessible to 
researchers outside the country, 
such as the Chinese journals. Thus, 
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meta-analyses that include only 
internationally accessible studies 
(which is, currently, often the case 
for meta-analyses) are likely to have 
language or location bias. Meta-
analyses that included only local studies 
could be even worse, as implied by 
Pan and colleagues’ study. Inclusion 
of every study published worldwide 
would probably still not totally solve 
the problem, as many studies are 
never published or their publication 
is delayed. Odds ratios thus estimated 
would normally be an over-estimate. 
Registration of studies is ideal and 
has been widely advocated for clinical 
trials [8]. Before such registration 
becomes universal practice, it would 
be important for journals, in selecting 
papers for publication, to emphasize 
the quality of the study rather than the 
size and direction of the odds ratio 
and the p-value of the statistical test. 
However, such an emphasis on quality 
(rather than the size and direction of 
the odds ratio) would not be much 
help to researchers who are currently 
doing meta-analyses. 
Current researchers must strive 
to not only identify relevant studies 
but also examine the possibility 
of publication bias in the results. 
Although better tools have yet to be 
developed [9,10], current methods 
for detection and adjustment for 
publication bias in meta-analyses of 
clinical trials would be useful for meta-
analyses of gene-disease associations 
[1,11,12].  
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